The B cell antigen receptor controls integrin activity through Btk and PLCgamma2

Area of Science:

• Immunology
• Cell Biology
• Molecular Signaling

Background:

• Integrin-mediated adhesion and B cell antigen receptor (BCR) signaling are vital for B cell development, function, and antigen-specific differentiation.
• Integrin alpha4beta1 (VLA-4) mediates B cell adhesion to vascular cell adhesion molecule-1 and fibronectin, influencing immune cell trafficking and function.

Purpose of the Study:

• To elucidate the signaling mechanisms by which the BCR controls integrin alpha4beta1-mediated adhesion in B cells.
• To identify key molecular players and pathways involved in BCR-dependent integrin regulation.
• To explore the role of Bruton's tyrosine kinase (Btk) in this process and its implications for X-linked agammaglobulinaemia (XLA).

Main Methods:

• A multidisciplinary approach combining biochemical assays, pharmacological inhibitors, and genetic analyses.
• Investigation of signaling cascades downstream of BCR activation, including kinase and calcium signaling pathways.
• Analysis of cytoskeletal reorganization and integrin clustering during adhesion.

Main Results:

• The BCR sequentially activates Lyn, Syk, PI3K, Bruton's tyrosine kinase (Btk), PLCgamma2, IP3R-mediated Ca2+ release, and PKC to control VLA-4 adhesion.
• Activation of MEK/ERK pathways is not required, and MEK/ERK/PKB co-activation is insufficient for this BCR-mediated adhesion.
• Btk is essential for integrin-mediated adhesion in both mature B cells and pre-B cells, involving cytoskeletal changes and integrin clustering.

Conclusions:

• The BCR exerts novel control over integrin alpha4beta1 activity, impacting B cell adhesion.
• This signaling pathway highlights a critical role for Btk in regulating B cell integrin function.
• Findings provide new insights into B cell development, differentiation, and the pathogenesis of XLA.